The federal healthcare ecosystem was just sent into a tailspin by the 5th U.S. Circuit Court of Appeals. In its landmark August 2026 ruling for Texas Medical Association v. HHS, the full 17-judge panel struck down the federal government’s formula for how health insurers calculate out-of-network payment benchmarks.
The court explicitly found that commercial carriers were using unlawful “ghost rates” — contracted placeholder prices for services a physician does not actually perform — and omitting clinician bonuses to artificially depress reimbursement metrics. While this ruling represents a major legal victory for independent physicians fighting against corporate manipulation, it also highlights the intense, hostile backlash targeting the landmark 2020 consumer protection law that ended surprise medical billing.
Congress passed that vital shield to remove innocent families from the middle of financial warfare between physicians and insurance companies, capping patient out-of-pocket costs at normal in-network rates. But as insurers face a staggering surge in independent dispute resolution payouts — which Centers for Medicare & Medicaid Services data show more than tripled to $14.9 billion in 2025 — a quiet, aggressive campaign is underway to completely bypass these hard-won patient and provider gains. Rather than accepting the neutral outcomes of independent dispute resolution, major insurance conglomerates have pivoted to aggressive courtroom strategies.
Commercial payers such as UnitedHealthcare, Elevance Health, and regional Blue Cross Blue Shield affiliates have filed massive federal lawsuits against medical billing representatives. These conglomerates are deploying complex fraud and racketeering allegations to overturn arbitration rulings. The clear motivation behind these lawsuits is financial leverage. Because independent arbitrators find in favor of physicians in roughly 85% of cases — recognizing that initial insurance payment offers are far too low to cover basic clinical operations — these carriers are trying to use the court system to bypass the law. However, judges are pushing back. Federal courts recently issued a string of rejections against these “lawfare” maneuvers, including a major California federal court dismissal against Anthem Blue Cross and a parallel Texas federal court dismissal rejecting Blue Cross Blue Shield of Texas’s attempt to relitigate arbitration determinations. Most recently, a Georgia federal court ruling tossed out a similar lawsuit by an Elevance Health affiliate, with the judge explicitly noting that the insurer’s legal theories lacked merit.
This corporate strategy goes beyond the courtroom; it directly affects the regulatory rate-setting process at the state level. For example, UnitedHealthcare recently sought an 8% premium rate hike in Maryland while simultaneously squeezing local providers by delaying and denying claims for necessary diagnostic services. Large insurance corporations continue to report soaring profits — such as UnitedHealthcare’s $86.3 billion in first-quarter revenue for 2026 — yet they routinely attempt to force families to shoulder the burden of excessive premiums while lowballing the front-line professionals who provide the care. It represents a highly coordinated game of regulatory chicken designed to depress the baseline valuation of clinical work.
Simultaneously, these same health insurance entities are exploiting loopholes regarding payment collections. In several jurisdictions, courts have restricted healthcare providers’ ability to enforce unpaid arbitration awards through standard federal lawsuits, emphasizing that the law relies on federal administrative complaints rather than direct judicial collection enforcement. Knowing that physicians have restricted legal avenues to immediately collect payment, health plans routinely withhold finalized payments. This trend is causing severe alarm among provider advocates, as documented in an analysis by Becker’s ASC Review, which warns that commercial payers are engaging in an unprecedented game of attrition by intentionally delaying the release of mandated funds. It is a highly coordinated effort by corporate insurers to strip the law of its teeth, rendering the independent arbitration process completely meaningless.
If these corporate strategies succeed in dismantling the enforcement of this consumer protection law, the adverse effects on public health and healthcare delivery will be severe. Independent medical practices and specialized physician groups cannot survive when their reimbursement is cut below overhead costs, or when legally mandated payments are withheld indefinitely. Financial starvation will force remaining independent clinics to sell out to massive hospital networks and private equity firms, which have historically driven up consumer costs and degraded the patient experience.
THE MALPRACTICE MONSTER DEVOURING HEALTHCARE
Worse, high-risk, highly demanding specialties such as emergency medicine, anesthesiology, and neonatology will become financially unviable. This will force specialists to leave vulnerable, rural, and economically disadvantaged regions entirely, creating massive care deserts. As insurance companies lowball reimbursement and refuse to pay arbitration awards, physicians will leave insurance networks altogether. While the law technically caps what a patient pays out of pocket, an insurance card is useless if there are no local physicians available to accept it.
The 5th Circuit ruling proves that the system was being mathematically manipulated behind closed doors. The judicial finding that agencies upended the legislative process by allowing “ghost rates” confirms that the current friction in independent dispute resolution stems directly from insurer evasion, not provider greed. We cannot allow these essential consumer protections to be quietly dismantled by corporate noncompliance from major insurers. When the rules governing fair mediation are broken, the safety net for both patients and physicians fails. Federal agencies and lawmakers must step in to strictly enforce the original terms of this legislation and mandate timely payments. We must ensure that the progress we have made to stabilize the healthcare system is not completely lost.
Eric Wargotz, MD, FCAP, is a practicing physician, a Clinical Professor Emeritus at the George Washington University School of Medicine and Health Sciences, a judge of the Orphans’ Court of Queen Anne’s County, Maryland, and the 178th president of MedChi, The Maryland State Medical Society. The views expressed in this piece are solely his own.